Bovine tuberculosis is a zoonotic disease of global public health concern. Development of diagnostic tools to improve test accuracy and efficiency in domestic livestock and enable surveillance of wildlife reservoirs would improve disease management and eradication efforts. Use of volatile organic compound analysis in breath and fecal samples is being developed and optimized as a means to detect disease in humans and animals. In this study we demonstrate that VOCs present in fecal samples can be used to discriminate between non-vaccinated and BCG-vaccinated cattle prior to and after Mycobacterium bovis challenge.
Introduction
Bovine tuberculosis (bTB), a zoonotic disease affecting international public health, agricultural, wildlife, and trade [1, 2] , is caused by Mycobacterium bovis. The etiological agent responsible for most of the 9.6 million annual human tuberculosis cases [3] is M. tuberculosis; however, approximately 30% of cases may be caused by M. bovis infection, especially in developing countries [4] where prevalences of livestock bTB may approach 10-14% [5] [6] [7] [8] . The economic costs associated with bTB are significant; from 2008-2009 estimated economic losses globally and in the United States (US) were $3 billion and $40 million, respectively [2] .
The US federal bTB eradication program has been successful in decreasing the prevalence of bTB to approximately 0.0006% [2] ; however, outbreaks in domestic cattle (Bos tarus) and
Animals and Mycobacterium bovis challenge
One to two day old Holstein bull calves (n = 20) were acquired from a M. bovis-free, M. avium paratuberculosis-monitored herd, and placed into a NADC BSL-3 agricultural facility for the duration of the study. Cattle were housed under environmental conditions appropriate for normal physiological thermoregulation; in separate biocontainment rooms; with no exchange of air, food, or water occurring between rooms. Diet consisted of alfalfa hay cubes and a commercial pelleted ration provided twice daily, and water ad libitum. All calves were castrated at 42-43 days of age (S1 Table) . One individual in the BCG treatment group was humanely euthanized prior to the completion of the study due to a non-study related health issue, decreasing the number of individuals in that cohort (n = 9). Given the low dose challenge and relatively short duration of the study, cattle did not develop clinical signs of bTB (cough, dyspnea, anorexia, weight loss) necessitating palliative therapy.
Mycobacterium bovis strain 10-7428_CO_Dairy_10-A (M. bovis strain 10-7428; USDA, APHIS designation) was used for the challenge inoculum. The inoculum was prepared using standard procedures in Middlebrook 7H9 liquid media (Becton Dickinson, Franklin Lakes, NJ, US) as described by Larsen et al 2005 [40] . Enumeration of M. bovis challenge inoculum was performed as previously described [41] . Calves were challenged by aerosol with M. bovis using the method described by Palmer et al 2002 [41] at 120-121 days of age.
Diagnostic tests performed
Blood samples were collected from all calves seven days prior to vaccination, 20, 42, and 56 days post-vaccination, nine, 16, and 70 days post-challenge for in vitro evaluation of cellular immune responses (CMI) to mycobacterial antigens. The CCT was performed according to USDA, APHIS circular 91-45-01 guidelines [42] on all animals 104 days post-challenge (7 days prior to necropsy). Balanced purified protein derivatives (PPDs) were obtained from the Brucella and Mycobacterial Reagents Section of The USDA National Veterinary Services Laboratory, Ames, IA. Calves were administered 0.1 mL (100 μg) M. bovis PPD (PPDb) and 0.1 mL (40 μg) M. avium PPD (PPDa) intradermally at separate clipped sites on the side of the neck. Calves were humanely euthanized by intravenous administration of sodium pentobarbital 111 days post-challenge. Necropsy procedures, and gross and microscopic assessment of lesions were performed as described in Palmer et al 2002 [41] . When microscopic lesions consistent with bTB were identified, adjacent sections were stained by the Ziehl Neelsen technique to visualize acid-fast bacilli. Mediastinal, tracheobronchial, medial retropharyngeal, and prefemoral lymph nodes and lungs were sampled for M. bovis isolation and identification as previously described [43] . Qualitative assessment of mycobacterial colonization was performed using standard mycobacterial culture techniques [44] with Middlebrook 7H11 selective agar plates (Becton Dickinson, Franklin Lakes, NJ, USA) incubated for 8 weeks at 37˚C. Confirmation of colonies was performed as previously described [45] using IS6110 real time PCR (RT-PCR).
Fecal sample collection
Fecal samples were collected per rectum from all calves one day prior to virulent M. bovis challenge and prior to necropsy. Samples were placed in air-tight 50 mL conical centrifuge tubes, and stored on ice until transport to the NADC Tuberculosis Research Laboratory. Fecal sample processing was performed in a Biosafety Class II cabinet (BSC-II). A 1.5 gm fecal aliquot was removed from each sample using a 3.0 mL hypodermic syringe modified by removing the apex of the syringe barrel. Feces were deposited in the bottom of a clean 20 mL amber glass vial (Wheaton, Millville, NJ, USA) and the vial sealed with an air-tight lid containing a PTFE-lined silicone septum. The outer surface of each vial was decontaminated with tuberculocidal disinfectant (Wexcide, Wexford Labs, Kirkwood, MO USA) and transported in a sealed transfer container to the ISU Atmospheric Air Quality Laboratory for analysis.
Sample preparation for GC/MS analysis and GC/MS conditions
Pre-concentration of VOCs was performed using a 2 cm 50/30 μm DVB/Carboxen/PDMS (57348-U, Supelco, Bellefonte, PA, USA) SPME fiber mounted in a CTC Combi PAL™ LEAP GC autosampler (LEAP Technologies, part of Trajan Family, Inc., Carrboro, NC, USA) equipped with a heated agitator (37˚C, 250 rpm agitation). Each sample vial was transferred to the heated agitator, thermally equilibrated for 10 minutes, followed by SPME insertion and headspace exposure for 45 min. The SPME fiber was then transferred and inserted into the GC inlet and desorbed with the GC inlet configured in splitless mode at 250˚C using helium (He) carrier gas (99.995% purity). Multi-Dimensional Gas Chromatography-Mass Spectrometry (MDGC-MS) analysis was performed on an Agilent 6890 GC with a restrictor guard column, non-polar capillary column (BP-5, 30.0 m x 530 μm inner diameter x 0.5 μm thickness, SGE, Austin, TX, USA) and polar capillary column (BP-20, 30.0 m x 530 μm inner diameter x 0.5 μm thickness, SGE, Austin, TX, USA) connected in series. Sample flow was split 3:1 via open split interface to an olfactometry port (not used in this research) and mass spectrometer, respectively. Flow to the mass spectrometer was determined by the fixed restrictor column inner diameter and excess effluent was directed to the olfactory sniff port. The carrier gas was set to constant pressure of 5.7 psi at the midpoint (connection point of the non-polar and polar column). Oven temperature was programmed as follows: 40˚C for 3.00 minutes, ramped to 240˚C at a rate of 7˚C/min, and held for 8.43 min. Transfer line to the MS was set at 280˚C, and heated zones were 150˚C for the single quadrupole and 230˚C for the source. The MS was operated in electron ionization (EI) mode, with the electron energy set to 70eV, scanning from m/z 34.0-350.0.
Data analysis
Files containing GC-MS data for two BCG-vaccinated animals were corrupted, resulting in exclusion of these animals from our analysis. Remaining BCG-vaccinated animals (n = 7) were placed into two samples groups based on post-challenge responses to challenge (Table 1) . To keep sample group sizes similar for analyses, four non-vaccinated animals were randomly selected for our analyses. Final sample group designations included BCG-vaccinated virulent M. bovis positive calves (BCGprePOS, BCGpostPOS; n = 3); BCG-vaccinated calves with no evidence of virulent M. bovis infection (BCGpreNEG, BCGpostNEG; n-4); and non-vaccinated virulent M. bovis positive calves (NVpre, NVpost; n = 4).
Baseline-corrected chromatograms were analyzed using the multi-group comparison feature in XCMS Online [46, 47] (www.xcmsonline.scripps.edu) to identify peak ion abundances that differed across sample groups. All remaining statistical analysis were performed using statistical packages available in "R" [48] [49] [50] . A principal component analysis (PCA) was performed on the statistically significant ions (α = 0.05, 1.5 fold difference), and the PC scores proportion of variance and cumulative proportion of variance were used to develop five class linear discriminant analysis (LDA) classification models. Training and test datasets containing 70% and 30% of the data were used to produce predicted classifications for each sample, and the results were compared to actual sample group assignment. Misclassification rates were calculated to evaluate the feasibility of using statistically significant ions to discriminate between the sample groups. The number of true positive (infected calves; NVpost, BCGpost-POS); true negative (pre-challenge treatment groups and the post-challenge non-infected BCG-vaccinated calves; NVpre, BCGpre, BCGpostNEG); false positive (true negative calves incorrectly classified as infected), and false negative (true positives incorrectly classified as non-infected) animals were summed. Sensitivity was calculated as the total number of true positives divided by the sum of the true positives plus false negatives, and SP was calculated as the total number of true negative samples divided by the sum of the true negatives plus false positives [51] . An agglomerative hierarchical cluster analysis using Ward's method was performed to further assess use of ion data as a means to discriminate between individual and grouped samples, and to test the robustness of the PCA and LDA classification models.
Statistically significant ion intensities identified by XCMS Online were retention time matched with total ion chromatographic (TIC) peaks using Agilent Mass Hunter software (Agilent Technologies, Santa Clara, CA, USA), and associated peak areas were incorporated into PCA and LDA analyses to assess the feasibility of using the identified peaks to discriminate between sample groups. Group mean peaks areas were calculated for each peak, and between groups mean peak area fold differences > = 3.0 and biological relevance were used to identify a suite of peaks that best allowed discrimination between the sample groups. This suite of selected peaks was reanalyzed to determine if a minimum number of peaks might be used to discriminate between the sample groups, and whether any peaks might function as biomarkers associated with disease and/or vaccination status. Peaks meeting a minimum spectral match probability > = 65% were tentatively identified using the National Institute of Standards and Technology (NIST) W8N08 database (www.nist.gov), the Kyoto Encyclopedia of Genes and Genomes database [52, 53] , and the Human Metabolome Database [54, 55] . When multiple compounds were tentatively identified at one retention time, all tentative compound identifications were considered based on the possibility of co-elution and likelihood that no reference library contains all known compounds.
Results

Diagnostic tests
Over the course of the study, no differences in overall health or clinical disease severity were observed among non-vaccinated or BCG-vaccinated calves prior to or after challenge with virulent M. bovis (excluding the BCG vaccinated animal euthanized prior to study completion).
Results of the CCT skin test and in vitro evaluation of cellular immune responses to mycobacterial antigens are published elsewhere [56] . Briefly, all calves were classified as reactors based upon standard interpretation of the CCT skin test [42] . 
Analysis of ion features
The analysis performed using XCMS Online identified 180 ions, with 105 ions meeting the criteria for statistical significance (α = 0.05; fold change ! 1.5). Visualization of the characteristics of the statistically significant ion features are presented as a cloud plot (S3 Fig) [57] . The ion PCA classification model was developed using 76 of the 105 statistically significant ions. Twenty-nine ions occurring at late retention times (> 34.0 min) attributed to baseline noise were excluded from the analysis. Results are depicted in a three dimensional (3D) scatterplot (Fig 1) . Pre-and post-challenge samples groups are distinctly separate within the three dimensional space. Separation is present between NVpre and all BCG-vaccinated (BCGprePOS, BCGpreNEG) sample groups. NVpost, BCGpostPOS and BCGpostNEG sample groups are distinctly separate as well. Five class LDA classification models were constructed using two through six PC scores. The model constructed using two PC scores resulted in correct classification of 95% of calves ( Table 2 ). All misclassifications consisted of NVpre calves incorrectly classified as BCGpre calves (i.e., true negatives classed into a different true negative group) which did not adversely affect effect SN:SP (100%; 100%). Classification models constructed using three through six PC scores contained no misclassifications, and calculated SN:SPs of 100%:100%.
The ion cluster analysis shows initial pairing of individual calves within respective sample groups. Subsequent progression places paired individuals into respective pre-and post-virulent M. bovis challenge groups (Fig 2) . The final clustering produces clear separation between pre-and post-challenge sample groups. Inter-group discrimination is present between NVpre and BCGpre animals. All BCGpreNEG and BCGprePOS samples are found within one cluster, indicating that these samples are similar prior to virulent M. bovis challenge. After challenge, BCGpostNEG and BCGpostPOS samples are found within separate, but closely associated clusters, indicating that while the presence of virulent M. bovis in BCGpostPOS animals has induced some difference in those individuals, they still are similar. The location of all NVpost-POS individuals into a distinct cluster indicates that lack of BCG-vaccination prior to challenge creates a strong inter-group variation.
Analysis of peak areas and compound identification. Ions identified as statistically significant were GC column retention time matched to 23 chromatographic peaks. Ten peaks were identified by single ion matches, while the remainder (n = 13) were matched to multiple ions. Peak area data were visually inspected for biological relevance, and using these criteria, eight peaks were excluded from consideration. Two additional peaks identified as silane-containing compounds were removed because they were likely contaminants eluted from the GC column or septa material, leaving 13 peaks available for further analysis and tentative compound identification.
The peak area PCA classification analysis was reliably capable of discriminating between the sample groups (Fig 3) . Separation of pre-and post-challenge samples is present indicating that exposure to virulent M. bovis induces distinct changes in all individuals regardless of vaccination status. Individuals within treatment groups cluster in close association indicating similarity. BCGpreNEG and BCGprePOS animals cluster together indicating that there is little difference between BCG-vaccinated individuals prior to virulent M. bovis challenge. The BCGpre sample group and NVpre sample groups are separate. Post-challenge the BCGpost-NEG and BCGpostPOS groups form separate clusters, indicating that the persistent presence of virulent M. bovis in BCGpostPOS animals induces differences between these groups. NVpost individuals form a separate cluster with the exception of one pre-challenge non-vaccinated animal (NVpost91).
LDA classification models were developed using two through four PCs. Models returning the lowest misclassification rates were constructed using two and four PC scores (Table 3) . No misclassifications were observed, and corresponding SN:SP were 100%:100%, respectively. The misclassification rate for the model constructed using three PC scores was 17%, with all misclassified samples (100%) consisting of BCGpostPOS calves misclassified as BCGpostNEG (false negative samples). The calculated SN:SP for this model were 83%:100%. Five class models were constructed using two through six principal component analysis (PCA) dimensional scores. Models resulting in optimal misclassifications (0%), and SN:SP (100%:100%) were constructed using three through six PC scores. The model constructed using two PC scores returned the highest misclassification rate (5%); however, all misclassifications (100%) consisted of NVpre (true negative) animals misclassified as BCGpreNEG animals (true negatives), which did not affect the SN:SP (100%:100%).
https://doi.org/10.1371/journal.pone.0179914.t002
The peak area cluster analysis shows pairing of individuals within treatment group designation (Fig 4) . As the hierarchical model progresses, two BCGpostPOS animals (BCGpostPOS84, BCGpostPOS86) group among the BCGpostNEG animals. The remaining BCGpostPOS animal occupies a separate space in the tree. In the next hierarchical progression, three groups are identified. NVpost animals form a distinct group; all pre-challenge animals (NVpre; BCGpre) fall within a second group; and all post-challenge BCG-vaccinated animals form a third group. The final two groupings consist of one cluster containing all NVpost animals, and another containing all the other animals, indicating that the NVpost cattle are truly unique compared to the other sampled populations. Within the group containing all other treatment groups, NVpre and BCGpre sample groups are distinct from the BCGpostNEG and BCGpostPOS groups. The two misclassified BCGpostPOS animals (BCGpostPOS84, BCGpostPOS86) are identical to those identified in the ion cluster analysis.
Tentative identifications of peaks and associated information are summarized in Table 4 . Briefly, compounds tentatively identified using a > = 65% probability match in the NISTW8N08 library include an alcohol; an aldehyde; an alkane; an imine; an indole; one ketone; a pyridine derivative; and a thioether. Five peaks could not be identified using this database. Compounds tentatively identified using the KEGG and HMDB databases that differed from NIST included an organosulfur; an amino acid; an alcohol; a salt of chloric acid; a fatty acid; and a dicarboxylic acid. Five peaks were not identified by KEGG or HMDB. Three compounds could not be identified by any of the databases used.
Fold changes in mean peak area between treatment groups were calculated to identify peaks with greatest potential to perform dependent (pre-vs. post-challenge) and independent (vaccination and infection status) groups comparisons (S2 Table) . A mean fold difference > = 3.0 was used to identify peaks that best allowed inter-and intra-groups discrimination. The results of this comparison demonstrate that while specific fecal VOC biomarkers indicative of vaccination and/or disease status were not identified, differentiation between groups is still possible using suites of VOCs (Table 5 ). In the NVpre vs. NVpost comparison, twelve peaks had mean peak area fold differences meeting our selection criteria, with six peaks (2-4, 7, 11-12) having the greatest differences. For the BCGpreNEG vs. BCGpostNEG comparison, 10 peaks were identified, with 7 peaks (1-5, 9, 10) providing best discrimination. Six peaks (1-5 and 10) out of eleven provide best differentiation between BCGprePOS and BCGpostPOS animals. NVpre and BCGpre animals are discriminated by one peak (peak 7). For the NVpre vs. BCGpostNEG groups comparison a suite of 11 peaks (1-10, 13) met our selection criteria, and four peaks (1-3, 7) had the greatest mean fold differences. Four of 11 peaks (1-3 and 7) allow best discrimination between NVpre and BCGpostPOS samples. Discrimination between NVpost and BCGpre animals is best achieved using five (2-4, 11, 12) of 11 peaks. Four (peaks 8, 10-12) of eight peaks are best capable of discriminating between NVpost and BCGpostNEG animals. A suite of seven VOCs was identified in the NVpost vs. BCGpostPOS comparison, with two peaks (8, 12) having the greatest mean fold difference. Two peaks (peaks 11 and 9) comprise the suite of VOCs best capable of discriminating between BCGpostNEG and BCGpostPOS animals. While we were unable to identify a specific biomarker indicative of vaccination status or presence of virulent M. bovis infection, the results of our analysis do demonstrate the merit in evaluating multiple VOCs as a means of identifying animal cohorts. Fecal volatile organic compound analysis to detect Mycobacterium bovis Potential sources, and cellular, biological or metabolic functions associated with each tentatively identified compound were explored using KEGG, HMDB, and literature searches [32, 38, [53] [54] [55] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] (Tables 6 and 7) . Extensive metabolic information relative to M. bovis is not published; therefore, we referred to information published for M. tuberculosis when necessary. Eight tentatively identified compounds could be associated with mammalian systems. Another eight compounds could be associated with microbial cellular function. Seven compounds appear associated with mycobacterial metabolism, seven have been identified in cattle, four appear to be involved in non-mycobacterial microbial metabolism, and two are associated with immunological function. Overlap occurs among multiple compounds. For example, citrulline is associated with macrophage metabolism and function; is produced as by-product of the urea cycle, and is utilized by rumen microflora to convert urea to ammonia. Models resulting in lowest misclassification (0%) and optimal SN:SP (100%:100%) were constructed using two and four PC scores. The model developed using three PC scores returned a misclassification rate of 83%. All misclassifications occurring (100%) in this model were false negatives (BCGpostPOS animals misclassified BCGpostNEG).
https://doi.org/10.1371/journal.pone.0179914.t003
Fecal volatile organic compound analysis to detect Mycobacterium bovis
Discussion
We were successful in discriminating between sample groups using statistically significant ion data extracted from our raw data by XCMS Online. The PCA performed on these data resulted in correct classification of all animals to their respective dependent (pre-and post-virulent M. bovis challenge) and independent (vaccination and infection) groups. The LDA classification models resulted in correct classification rates of 95-100% (0-5% misclassification). The cluster analysis misclassed two BCGpostPOS animals as BCGpostNEG (false negatives). The best use of the ion data was to evaluate the raw data in a preliminary format. For example, in this study, the number of statistically significant ions associated with a specific peak inconsistently ranged from a single ion to six ions, potentially biasing the analysis toward over or under representation of certain chromatographic peaks. Because ion count data do not reflect peak area, ion intensity does not equate to differences in VOCs between individuals or treatment groups. The intensity of a single ion may not represent the parent ion for a compound, and may result from the ionization of multiple co-eluting compounds that share a common ionization fragment. Finally, relative to the intended purpose of our research (assessment of host-pathogen interactions), associated peaks need to be biologically logical in occurrence. This cannot be ascertained using ion data. The results generated by the peak area classification models are epidemiologically acceptable. The calculated SN:SP of our optimal LDA classification models were 100%:100%, and 83%:100% for the model that performed poorly. In comparison, the SN:SP of the CFT, comparative CCT, and the IFN-ɣ assay have been reported to range from 68-96.8%:96-98%; 55.1-93.5%:88.8-100% [2] ; and 73-100%:87.7-99.2% [78] , respectively. These results could be adequately visualized in the PCA scatterplot. The cluster analysis misclassified two BCGpostPOS animals as BCGpostNEG (false negatives). An advantage of the cluster analysis was its ability to independently group data, eliminating potential selection bias on the part of the researcher, unlike LDA which requires that the groups be defined prior to analysis. As such, we found the cluster analysis a helpful tool to evaluate the robustness of our other analyses. Fecal volatile organic compound analysis to detect Mycobacterium bovis We were successful in identifying associations between VOCs and vaccination status and/ or the presence of M. bovis infection. While individual VOCs did not appear to be exclusively associated with sample cohorts, use of inter-and intra-group mean peak area fold differences did identify suites of VOCs that allowed discrimination between independent and dependent treatment groups. An analogy would be use of a blood chemistry analysis to assess the overall function of all of an animal's health, followed by evaluation of specific suites of individual blood chemistries to assess renal, hepatic or pancreatic function.
These findings may infer that the changes noted are associated with host immunological function; however, given that the BCG-vaccine is comprised of attenuated M. bovis that can persist in host tissues [79] , and the pathological persistence of virulent M. bovis in infected hosts, it is plausible that some VOC changes reflect microbial and/or host metabolic, homeostatic, or physiological processes. In this study, five of our tentatively identified compounds have been associated with M. tuberculosis metabolism. Because reference libraries are not exclusive or complete, and the likelihood that biological samples contain unknown compounds. it is important to consider all potential chemical or metabolic matches [80] . Attempting to identify unknown compounds, or those with a low probability matches using a battery of analytical standards is cost prohibitive and was not performed in this study.
We can state with confidence that our findings demonstrate it is possible to differentiate between non-and BCG-vaccinated Holstein cattle before and after virulent M. bovis challenge using fecal VOCs collected by methods similar but more refined than those used in a similar study of white-tailed deer [38] . Two compounds identified by both studies (2-dodecanone, 2-methyl pyridine) shared the same trend in peak area fold difference between treatment groups (cattle: NVpost > BCGpostPOS > BCGpostNEG > BCGpre > NVpre; white-tailed deer: NVpost > BCGpostNEG > BCGpre > NVpre, there were no BCGpostPOS deer in this study). A third compound (1H-indole) followed the described sample progression pattern in white-tailed deer, and progressed by treatment group in cattle as NVpost > BCGpostPOS > BCGpostNEG > NVpre = BCGpre, results that are similar and warrant further exploration. None of the compounds found in the suite of breath VOCs used to discriminate between healthy and virulent M. bovis infected cattle in our pilot study were identified here [32] . Several Peak area mean fold differences were calculated for dependent (pre-vs. post-challenge) and independent (vaccination and infection status) treatment group comparisons. Suites of peaks with fold differences meeting a minimum selection criteria (> = 3.0) were identified for each comparison. Peaks with greatest mean fold differences are denoted in black. Peaks with lower mean fold differences are noted in gray. Peaks that do not meet the selection criteria are denoted in white.
https://doi.org/10.1371/journal.pone.0179914.t005 Table 6 . Potential sources of peak compounds, and order of sample group mean peak areas. • Identified in feces of white-tailed deer.
Peak Tentative Compound Identification
• VOC produced by cattle. HEVs in lymphoid tissues which support lymphocyte extravasation from blood.
• Can be present in food, chlorinated water, or in some disinfectants
Fecal volatile organic compound analysis to detect Mycobacterium bovis • Derivative of chlorophyll.
• Found in bovine liver, heart, muscle, fat.
• • Anion (succinate) is a component of the citric acid cycle.
• Succinate dehydrogenase (SDH) is important in mitochondrial function (part of respiratory chain and Krebs cycle).
• Produced by fermentation of glucose.
• Succinic acid producing bacteria have been isolated from the rumen of cattle.
• M. tuberculosis utilizes the anion (succinate) to sustain membrane potential, ATP synthesis, and anaplerosis, and can remodel the tricarboxylic acid cycle to increase production of succinate in response to hypoxia.
• Methyl-nicotinate has been reported as a potential biomarker for M. tuberculosis. Nicotinamide is a compound with known tuberculocidal activity.
Metabolomics data base and literature searches were utilized to identify potential sources and associations of the VOCs identified. Sample groups are arranged in descending order of mean peak area values to demonstrate how each VOC may be used to identify sample groups.
https://doi.org/10.1371/journal.pone.0179914.t006
Fecal volatile organic compound analysis to detect Mycobacterium bovis factors such as the sample (breath vs. feces); VOC collection method (sorbent tubes vs. SPME); and differences in GCMS analysis methods may have contributed to this disparity. Five identified compounds (1H-indole, 2-methyl pyridine, benzaldehyde, dimethyl sulfide, dimethyl sulfone) have been associated with normal ruminant physiology in cattle [61, 81] . Dimethyl sulfide has been previously reported in the literature as a compound associated with M. bovis cultures [58] . Eight of our tentatively identified compounds have not been previously reported in our prior studies or elsewhere. We were not successful in detecting a specific candidate VOC biomarker to indicate BCG vaccination or pathogenic M. bovis exposure/infection. Tentative biomarkers associated with M. tuberculosis infection have been suggested [19, 58, 82, 83] ; however, because of the Fecal volatile organic compound analysis to detect Mycobacterium bovis influence of diet, behavior, and other factors, identification of one or two compounds as specific indicators of infection by a unique pathogen is difficult. For example, methyl-nicotinate, a compound proposed as a M. tuberculosis biomarker, can be found in the breath of smokers [84] , is used as a flavoring ingredient, and is present in coffee, various nuts, alcoholic beverages, and fruits [54, 55] . Instead, we demonstrate that a suites of VOCs may be used to discriminate between unique treatment groups prior and after challenge with virulent M. bovis. If the VOCs identified in this study are associated only with non-specific host adaptive or immune responses to pathogen presence, comparative research must be conducted exploring the suites of VOCs produced by other infectious diseases of cattle.
Strengths of our study include analysis of samples from physically similar Holstein steers housed in controlled environmental and husbandry conditions, and exposed to a known concentration of M. bovis inoculum. Weaknesses include changes in our collection and sample analysis method which were intentional and done with the understanding that retrospective comparison to previous results may be compromised. The small number of samples available for analysis was unavoidable given the expense of housing large ungulates in confinement; however; this study represents the third time we have been able to discriminate between noninfected and M. bovis infected animals using VOCs present in breath [32] or feces [38] . Repeatability infers reliability, and repeated studies will allow compilation of a library of identified VOCs that will better define suites of VOCs appropriate for identification of disease or vaccination status.
Developing a disease surveillance modality that uses a readily accessible biological sample (feces) collected directly from domestic livestock would improve surveillance strategies by reducing or eliminating animal handling events, decrease animal stress, allow better opportunity for retesting and storage of samples, eliminate the need for specialized laboratory training, and improve test turnaround time. Use of feces collected from environments where wildlife reservoirs of M. bovis or other significant pathogens reside would vastly improve the ability of wildlife managers to assess the health status of wildlife, develop wildlife management strategies enhancing control of agriculturally important diseases, and provide public health support. The capability to differentiate between BCG-vaccinated and non-vaccinated animals prior to and after exposure to M. bovis would provide a crucial surveillance modality to control and eradicate bovine tuberculosis in domestic animal and wildlife reservoir populations. Continued use and refinement of our sampling method and analysis is therefore designed to lead toward development of a portable, labor and cost efficient tool that can accurately identify non-vaccinated and/or vaccinated domestic and wild animals infected with M. bovis or other pathogens of zoonotic or agricultural importance.
Supporting information S1 Table. Study timeline from initiation of study to completion. This table documents all diagnostic and fecal sampling time-points, age at vaccination and M. bovis challenge, and all other procedures pertinent to the study beginning with purchase of calves through euthanasia and necropsy. (TIF) S2 Table. Comparative differences in mean peak areas of sample groups. Differences in mean peak area were calculated for dependent (pre-vs. post-challenge) and independent (vaccination and infection status) comparisons. A minimum fold difference < = 3.0 criteria was used to identify suites of VOCs useful in discriminating between sample groups. (TIF) 
